July 24, 2010

Conference Transcript for FDA Converged Communications and Health Care Devices Impact on Regulation; Public Meeting: Day 2

The U.S. Food and Drug Administration (FDA) has been considering how and when to regulate mobile health applications that are used on wireless phones without altering the phone’s primary function as a mobile telecommunication device. These mobile devices such as cell phones, PDAs, and other wireless technologies used to collect health data and transmit that information between medical personnel are considered mobile health, or mHealth. This document is a transcript of the procedings of the first day of a public meeting on the topic.